Approval · Notice of Compliance 38450 · 2026
CARVYKTI: Notice of Compliance 38450
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38450
- Date
- October 9, 2026
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of commitments 2a and 2b of the Letter of Undertaking dated January 13, 2023
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CARVYKTI | Not yet assigned | — |
Medicinal ingredients
- CILTACABTAGENE AUTOLEUCEL 100,000,000 CELLS per BAG